Bildkälla: Stockfoto

OssDsign: Growing above expectations - SEB

OssDsign reported Q3 Catalyst sales of SEK 16.7m (+7% vs SEBe SEK 15.9m), up 155% y/y. Our 2024E-25E Catalyst sales forecasts are mostly unchanged (negative forex impact), which implies organic growth of 70% for 2024 and 46% for 2025. We believe this path should take OssDsign into positive cash flow territory by 2026 and reiterate our mid-point equity value of SEK 9/share. We think 2024 could be exciting with clinical data a potential trigger.

OssDsign reported Q3 Catalyst sales of SEK 16.7m (+7% vs SEBe SEK 15.9m), up 155% y/y. Our 2024E-25E Catalyst sales forecasts are mostly unchanged (negative forex impact), which implies organic growth of 70% for 2024 and 46% for 2025. We believe this path should take OssDsign into positive cash flow territory by 2026 and reiterate our mid-point equity value of SEK 9/share. We think 2024 could be exciting with clinical data a potential trigger.
Börsvärldens nyhetsbrev
ANNONSER